QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Monopar Therapeutics (MNPR) SEC Filings & 10K Form

$0.83
-0.17 (-17.00%)
(As of 02/29/2024 ET)

Recent Monopar Therapeutics SEC Filings

DateFilerForm TypeView
02/28/2024
12:45 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:59 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
6:36 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:37 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:38 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:39 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:33 PM
Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:34 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:35 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:36 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:37 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:30 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:31 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:32 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:34 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
4:16 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
5:45 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:49 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:49 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:50 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:51 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2023
6:03 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:50 PM
Monopar Therapeutics (Filer)
Form ARS
04/04/2023
4:16 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
4:17 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
4:18 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2023
4:01 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2023
6:03 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2023
6:05 AM
Monopar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MNPR) was last updated on 2/29/2024 by MarketBeat.com Staff